CJC-1295 / Ipamorelin Blend research vial
Longevity

CJC-1295 / Ipamorelin Blend

A research blend of a GHRH analog (CJC-1295) and a selective growth-hormone secretagogue (Ipamorelin), studied in preclinical endocrine research.

10 mg · lyophilized · purity verified by HPLC
$79.99
Quantity
1
COA available on every batch

Customers also frequently order with

Reference only, for laboratory research. Nothing on this page describes use of this material in humans or animals.

What research has studied about CJC-1295 / Ipamorelin Blend

This blend pairs two peptides studied together in growth-hormone-axis research. CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective growth-hormone secretagogue that acts at the ghrelin/GHS receptor. Together they are studied as complementary stimuli of the pituitary.

In laboratory and animal-model research, CJC-1295 has been characterized for prolonged stimulation of growth hormone and IGF-1, and Ipamorelin for selective growth-hormone release with minimal effect on other pituitary hormones. These are preclinical observations reported in the literature; nothing here describes use in humans.

Certificate of Analysis

Every CJC-1295 / Ipamorelin lot is tested by an independent third-party lab and ships with its lot-matched Certificate of Analysis. This lot’s certificate is available on request — contact us and we will send it over.

Specifications

CompoundCJC-1295 / Ipamorelin Blend
Available sizes10 mg
FormLyophilized powder
PurityMeasured by HPLC; see the Certificate of Analysis for the lot
StorageStore cold and away from light per your lab protocol
Intended useLaboratory and research use only
Handling is a bench procedure for a research material. See our guides on how research peptides are reconstituted and how they should be stored.

Research sources

  1. Teichman SL, et al., "Prolonged stimulation of growth hormone and IGF-I secretion by CJC-1295, a long-acting analog of GHRH," J. Clin. Endocrinol. Metab. 91(3):799–805 (2006). PMID 16822960
  2. Raun K, et al., "Ipamorelin, the first selective growth hormone secretagogue," Eur. J. Endocrinol. 139(5):552–561 (1998). PMID 9849822

Frequently asked questions

What is the CJC-1295 / Ipamorelin blend?

It is a research blend of a GHRH analog (CJC-1295) and a selective growth-hormone secretagogue (Ipamorelin), studied together in endocrine research. Steadfast supplies it as a lyophilized research material for laboratory use only.

What has research studied about these peptides?

Preclinical studies have characterized CJC-1295's prolonged stimulation of growth hormone/IGF-1 and Ipamorelin's selective growth-hormone release in laboratory and animal models.

Is it intended for human use?

No. It is a research chemical for in-vitro laboratory research only, not a drug or supplement.

All Steadfast Research Group products are for laboratory and research use only. Not for human consumption. Not a drug; not intended to diagnose, treat, cure, or prevent any disease. Nothing on this page is medical advice.